Cell Innovation Partners is a joint venture between Reprocell, a biomedical company, and Shinsei Corporate Investment, the venture capital investment arm of Shinsei Bank. The firm is set up to manage a JPY 900 million fund, Cell Innovation Partners, targeting venture capital opportunities within Japan and overseas in the biotechnology, biomedical, and healthcare sectors.
Venture Capital
1 funds found in our dataset.
Built for investment teams that need to move faster.
Intelligently process data room financials, generate auditable analyses, and export IC-ready deliverables.